A prospective randomized trial to determine the benefit of surgical resection of residual disease following response of small cell lung cancer to combination chemotherapy.
第一作者:
T,Lad
作者:
医学主题词
成年人(Adult);老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);癌, 小细胞(Carcinoma, Small Cell);环磷酰胺(Cyclophosphamide);多柔比星(Doxorubicin);女(雌)性(Female);人类(Humans);肺肿瘤(Lung Neoplasms);男(雄)性(Male);中年人(Middle Aged);肿瘤, 残余(Neoplasm, Residual);前瞻性研究(Prospective Studies);存活率(Survival Rate);胸廓切开术(Thoracotomy);长春新碱(Vincristine)
DOI
10.1378/chest.106.6_supplement.320s
PMID
7988254
发布时间
2022-04-09
- 浏览2
Chest
320S-323S页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



